Nemeth Z, Paulinne Bukovics M, Sumegi L, Sturm G, Takacs I, Simon-Szabo L
Int J Mol Sci. 2025; 26(2).
PMID: 39859540
PMC: 11765957.
DOI: 10.3390/ijms26020827.
Mei J, Luo Z, Cai Y, Wan R, Qian Z, Chu J
Research (Wash D C). 2025; 8():0590.
PMID: 39845707
PMC: 11751204.
DOI: 10.34133/research.0590.
Gallucci G, Larocca M, Navazio A, Turazza F, Inno A, Canale M
Int J Mol Sci. 2025; 26(1.
PMID: 39796190
PMC: 11719480.
DOI: 10.3390/ijms26010334.
Buzaglo G, Telles G, Araujo R, Junior G, Ruberti O, Ferreira M
Int J Mol Sci. 2025; 25(24.
PMID: 39769501
PMC: 11678861.
DOI: 10.3390/ijms252413740.
Xiong Z, Yuan Y, Yang Y, Qiu B, Bai Y, Wang T
Front Oncol. 2024; 14:1510578.
PMID: 39737404
PMC: 11682983.
DOI: 10.3389/fonc.2024.1510578.
Telemedicine-based exercise intervention in cancer survivors: a non-randomized controlled trial.
Krell V, Porst J, Hafermann L, Kuhn J, Greiss F, Romer C
Sci Rep. 2024; 14(1):30615.
PMID: 39715788
PMC: 11666603.
DOI: 10.1038/s41598-024-83846-x.
Swimming upregulates APOL3 through regulating macrophage polarization to inhibit glycolysis and the development of melanoma.
Lyu Z, Mahenderan A, Radhakrishnan A, Chin Y, Yin C
3 Biotech. 2024; 14(12):307.
PMID: 39583207
PMC: 11582285.
DOI: 10.1007/s13205-024-04150-z.
Clinically relevant body composition phenotypes are associated with distinct circulating cytokine and metabolomic milieus in epithelial ovarian cancer patients.
Davis E, Hsiao H, Barone N, Rosario S, Cannioto R
Front Immunol. 2024; 15:1419257.
PMID: 39575261
PMC: 11578747.
DOI: 10.3389/fimmu.2024.1419257.
Metabolic reprogramming and therapeutic resistance in primary and metastatic breast cancer.
Liu S, Zhang X, Wang W, Li X, Sun X, Zhao Y
Mol Cancer. 2024; 23(1):261.
PMID: 39574178
PMC: 11580516.
DOI: 10.1186/s12943-024-02165-x.
Exploring the effect of exercise training on breast cancer's pathologic response and tumor immune microenvironment after neoadjuvant chemotherapy.
Guedes H, Joao D, Caldas M, Antunes P, Costa T, Alves A
Support Care Cancer. 2024; 32(11):739.
PMID: 39432116
DOI: 10.1007/s00520-024-08942-0.
Impact of exercise on cancer: mechanistic perspectives and new insights.
Feng Y, Feng X, Wan R, Luo Z, Qu L, Wang Q
Front Immunol. 2024; 15:1474770.
PMID: 39346906
PMC: 11427289.
DOI: 10.3389/fimmu.2024.1474770.
Molecular Aspects in the Development of Type 2 Diabetes and Possible Preventive and Complementary Therapies.
Simon-Szabo L, Lizak B, Sturm G, Somogyi A, Takacs I, Nemeth Z
Int J Mol Sci. 2024; 25(16).
PMID: 39201799
PMC: 11354764.
DOI: 10.3390/ijms25169113.
Cancer Prevention and Treatment Based on Lifestyles.
Amraiz D, Kiani A, Awan U, Amraiz T, Awan B, Irfan M
Cancer Treat Res. 2024; 191:245-279.
PMID: 39133411
DOI: 10.1007/978-3-031-55622-7_10.
Muscle-derived exosomes and exercise in cancer prevention.
Vitucci D, Martone D, Alfieri A, Buono P
Front Mol Med. 2024; 3:1202190.
PMID: 39086668
PMC: 11285545.
DOI: 10.3389/fmmed.2023.1202190.
Nano-Assisted Radiotherapy Strategies: New Opportunities for Treatment of Non-Small Cell Lung Cancer.
Zhao L, Li M, Shen C, Luo Y, Hou X, Qi Y
Research (Wash D C). 2024; 7:0429.
PMID: 39045421
PMC: 11265788.
DOI: 10.34133/research.0429.
Moderate-intensity aerobic exercise training improves CD8 tumor-infiltrating lymphocytes effector function by reducing mitochondrial loss.
Voltarelli V, Amano M, Tobias G, Borges G, Oliveira da Paixao A, Pereira M
iScience. 2024; 27(6):110121.
PMID: 38957793
PMC: 11217614.
DOI: 10.1016/j.isci.2024.110121.
Quality of life assessment in diffuse large B-cell lymphoma (DLBCL) in REFLECT: a prospective, non-interventional, multicenter, German study, assessing Sandoz rituximab in combination with CHOP.
Kubuschok B, Otremba B, Welslau M, Topaly J, Wolff T, Lenz G
Ann Hematol. 2024; 103(8):3165-3178.
PMID: 38900302
PMC: 11283426.
DOI: 10.1007/s00277-024-05850-5.
Dose/Exposure Relationship of Exercise and Distant Recurrence in Primary Breast Cancer.
Soldato D, Michiels S, Havas J, Di Meglio A, Pagliuca M, Franzoi M
J Clin Oncol. 2024; 42(25):3022-3032.
PMID: 38838281
PMC: 11361355.
DOI: 10.1200/JCO.23.01959.
The association of body composition phenotypes before chemotherapy with epithelial ovarian cancer mortality.
Davis E, Attwood K, Prunier J, Paragh G, Joseph J, Klein A
J Natl Cancer Inst. 2024; 116(9):1513-1524.
PMID: 38802116
PMC: 11378317.
DOI: 10.1093/jnci/djae112.
Health Behavior Change Intervention Preferences Expressed by American Indian Cancer Survivors From a Southwest Tribal Community: Semistructured Interview Study.
Erdrich J, Cordova-Marks F, Carson W, Bea J, Montfort W, Thomson C
JMIR Form Res. 2024; 8:e51669.
PMID: 38536214
PMC: 11007609.
DOI: 10.2196/51669.